Adjunctive Therapy With Brinzolamide 1% Ophthalmic Suspension (Azopt®) in Patients With Open-Angle Glaucoma or Ocular Hypertension Maintained on Timolol Therapy
Authors:
- the Brinzolamide Adjunctive Therapy Study GroupTGthe Brinzolamide Adjunctive Therapy Study Group
- 1 January 2000
- journal article
- clinical trial
- Published by Elsevier in Survey of Ophthalmology
- Vol. 44, S163-S168
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- The Efficacy and Safety of Brinzolamide 1% Ophthalmic Suspension (Azopt®) as a Primary Therapy in Patients With Open-Angle Glaucoma or Ocular HypertensionSurvey of Ophthalmology, 2000
- Clinical efficacy and safety of brinzolamide (Azopt™), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertensionAmerican Journal of Ophthalmology, 1998
- The Use of Dorzolamide and Pilocarpine as Adjunctive Therapy to Timolol in Patients with Elevated Intraocular PressureOphthalmology, 1996
- New Developments in the Drug Treatment of GlaucomaDrugs, 1991